Myasthenia Gravis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
Condition:   Myasthenia Gravis, Generalized Interventions:   Drug: Rituximab;   Other: Placebo Sponsor:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
Condition:   To Assess Whether Rituximab Can Reduce MG-related Functional Impairment Interventions:   Drug: Rituximab;   Other: Placebo Sponsor:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis
Condition:   Myasthenia Gravis Intervention:   Drug: CD19 CAR-T cells injection Sponsor:   Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2023 Category: Research Source Type: clinical trials